Cambridge Epigenetix

Cambridge Epigenetix is the Cambridge, UK genomics and epigenetics company founded on the six-base genome — resolving the four canonical DNA bases plus 5-methylcytosine and 5-hydroxymethylcytosine from a single low-input sample in one experiment — and it rebranded to biomodal in 2023. DUPLICATE RECORD: this stub was created from the secondary-market harvest backlog (Forge Global listing) under the company's former name and profiles the same company already held in the API Evangelist network as all/biomodal, which carries the live profile (CLI command surface, domain security, blog archive, screenshots and Kin Score history). The legacy domain cambridge-epigenetix.com now 301-redirects to biomodal.com, so there is no independent Cambridge Epigenetix surface to profile. No API surface has been registered here and no artifacts have been generated, so this record does not split the company across two Kin Scores. It is queued for the duplicate-retirement procedure (survivor: biomodal).

Cambridge Epigenetix is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Genomics, Epigenetics, and Multiomics.

3.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyLife SciencesGenomicsEpigeneticsMultiomicsDNA SequencingDuplicate

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 3.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 3.9 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cambridge-epigenetix: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: cambridge-epigenetix
name: Cambridge Epigenetix
description: 'Cambridge Epigenetix is the Cambridge, UK genomics and epigenetics company founded on the six-base genome —
  resolving the four canonical DNA bases plus 5-methylcytosine and 5-hydroxymethylcytosine from a single low-input sample
  in one experiment — and it rebranded to biomodal in 2023. DUPLICATE RECORD: this stub was created from the secondary-market
  harvest backlog (Forge Global listing) under the company''s former name and profiles the same company already held in the
  API Evangelist network as all/biomodal, which carries the live profile (CLI command surface, domain security, blog archive,
  screenshots and Kin Score history). The legacy domain cambridge-epigenetix.com now 301-redirects to biomodal.com, so there
  is no independent Cambridge Epigenetix surface to profile. No API surface has been registered here and no artifacts have
  been generated, so this record does not split the company across two Kin Scores. It is queued for the duplicate-retirement
  procedure (survivor: biomodal).'
url: https://raw.githubusercontent.com/api-evangelist/cambridge-epigenetix/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: duplicate
x-tier-reason: duplicate-of-biomodal
x-renamed-to: biomodal
x-canonical-domain: https://biomodal.com
x-duplicate-of:
  slug: biomodal
  survivor: true
  reason: biomodal is the same company under its current name and holds the live profile (CLI, domain security, blogs, screenshots,
    Kin Score history); all/cambridge-epigenetix is an identity-only stub harvested from a secondary-market listing under
    the company's former name.
  evidence:
  - source: https://cambridge-epigenetix.com/
    http_status: 301
    note: Legacy company domain 301-redirects to https://biomodal.com/ — the rebrand is served by the company's own DNS/edge,
      not inferred.
  - source: https://www.cambridge-epigenetix.com/
    http_status: 301
    note: www host redirects to https://biomodal.com/ as well.
  - source: https://biomodal.com/
    http_status: 200
    note: Live company site under the current name; already registered as the Website on all/biomodal.
  - source: https://app.biomodal.com/
    http_status: 200
    note: 'Live API host, responds text/plain "Welcome to the biomodal API"; the same host all/biomodal records. Routed to
      the survivor as a finding — it is currently pointed at there only as type: Login.'
  - source: https://software-docs.biomodal.com/en/latest/index.html
    http_status: 200
    note: Software documentation (Sphinx) for the biomodal CLI and duet pipeline — the developer surface captured on all/biomodal.
  determined: '2026-08-09'
  procedure: duplicate-provider-retirement (retired.yml redirects; port only unique work to the survivor)
specificationVersion: '0.20'
created: '2026-08-09'
modified: '2026-08-09'
tags:
- Company
- Life Sciences
- Genomics
- Epigenetics
- Multiomics
- DNA Sequencing
- Duplicate
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://biomodal.com
- type: SecondaryMarket
  url: https://forgeglobal.com/cambridge-epigenetix_stock/
x-enrichment:
  date: '2026-08-09'
  status: nochange
  artifacts_added: 0
  pass: local-v1
  note: Enrichment intentionally withheld — contract discovery resolved this stub to an existing network provider (biomodal,
    the company's current name). Building artifacts here would create a second scored profile for one company. Findings routed
    to the survivor.
x-coverage:
  state: none
  reason: defunct
  detail: Cambridge Epigenetix rebranded to biomodal in 2023 and cambridge-epigenetix.com now 301-redirects to biomodal.com,
    so no surface remains under this name — the company's live developer surface is profiled in the network as all/biomodal.
  evidence:
  - url: https://cambridge-epigenetix.com/
    status: 301
  - url: https://biomodal.com/
    status: 200
  - url: https://forgeglobal.com/cambridge-epigenetix_stock/
    status: 403
  checked: '2026-08-09'